Navigation Links
VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week

SAN DIEGO, CA, June 16, 2008 -- VaxInnate Corporation announced today that it will discuss its novel proprietary technology for producing seasonal and pandemic influenza vaccines during BIO 2008 here this week.

VaxInnate will participate in the following three BIO 2008 panel discussions:

On Tuesday, June 17th

  • "Influenza Research and Surveillance: Preparing for the Next Pandemic,"
    8:15-9:45 am in Room 29A including Robert Becker, PhD, MBA, VaxInnate's Vice President of Business Development

On Thursday, June 19th

  • "Vaccine Renaissance,"
    8:30-10:00 am, Room 29A including Dr. Robert Becker

  • "Moore's Law for Biomanufacturing: Innovation in a Maturing Biologicals Industry,"
    4:00 - 5:30 pm, Room 29B including Edward Arcuri, PhD, VaxInnate's Chief of Operations (COO)

VaxInnate's Approach

VaxInnate's novel technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of influenza vaccines.

VaxInnate's approach to developing and producing influenza vaccines is based upon a proprietary combination of toll-like receptor (TLR) mediated immune enhancement and recombinant bacterial production of vaccine antigen. This proprietary technology could significantly reduce the time required to produce supplies of influenza vaccine sufficient to meet national and even global needs.

VaxInnate's use of bacterial expression for production of influenza vaccines does not require costly expansion of manufacturing capacity, as do other influenza vaccine products. Due to its efficiency and transferability, VaxInnate's flu vaccine could instead be produced in existing biotechnology facilities that have microbial production capacity.

No other vaccine technology in use or in development today has these same potential capabilities.

Results of a Phase I study of VaxInnate's M2e universal vaccine candidate will be available this summer. The company plans to present the study data at a major scientific conference later this year and publish the data in a peer-reviewed journal.


Contact: Janet Skidmore

Related biology news :

1. Scientists, policymakers and industry leaders gather to discuss ocean iron fertilization
2. Book on weeds and invasive plants discusses how to manage them using ecological approaches
3. Presidents of Iceland, Bangladesh to discuss global climate change in New Orleans
4. Art meets science: Engineer discusses his photographs in free UH lecture
5. Leading researchers and experts gather to discuss latest advancements in drug discovery
6. Japanese and German researchers meet to discuss climate change
7. Biophysical Society to host discussions on the teaching of evolution and on the energy crisis
8. MIT professor to discuss future of biofuels
9. DHS, business leaders discuss technology to protect US at Homeland Security conference
10. Wildlife Conservation Society study finds seasonal seas save corals with tough love
11. NASA technology helps predict and prevent future pandemic outbreaks
Post Your Comments:
(Date:11/20/2015)... OXFORD, Connecticut , November 20, 2015 ... biometric authentication company focused on the growing mobile commerce ... its CEO, Gino Pereira , was recently interviewed ... The interview will air on this weekend on ... Bloomberg Latin America . --> NXTD ) ...
(Date:11/17/2015)... 17, 2015 Paris from ... --> Paris from 17 th until ... biometrics innovation leader, has invented the first combined scanner in ... same scanning surface. Until now two different scanners were required: ... can capture both on the same surface. This innovation ...
(Date:11/12/2015)...  A golden retriever that stayed healthy despite having ... provided a new lead for treating this muscle-wasting disorder, ... of MIT and Harvard and the University of São ... Cell, pinpoints a protective gene that boosts ... The Boston Children,s lab of Lou Kunkel , ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... , Nov. 25, 2015  Neurocrine Biosciences, Inc. ... Gorman , President and CEO of Neurocrine Biosciences, will ... Conference in New York . ... visit the website approximately 5 minutes prior to the ... replay of the presentation will be available on the ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology: